Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
or

Sarepta Therapeutics (SRPT)

Sarepta Therapeutics (SRPT)
63.00 x 1 66.00 x 656
Pre-market by (Cboe BZX)
70.41 -1.40 (-1.95%) 03/28/25 [NASDAQ]
63.00 x 1 66.00 x 656
Pre-market 66.00 -4.41 (-6.26%) 08:54 ET
Quote Overview for Mon, Mar 31st, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
65.97
Day High
65.97
Open 65.97
Previous Close 70.41 70.41
Volume 47,369 47,369
Avg Vol 2,137,828 2,137,828
Stochastic %K 3.46% 3.46%
Weighted Alpha -58.55 -58.55
5-Day Change -10.36 (-13.57%) -10.36 (-13.57%)
52-Week Range 65.97 - 173.25 65.97 - 173.25
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,832,023
  • Shares Outstanding, K 97,032
  • Annual Sales, $ 1,902 M
  • Annual Income, $ 235,240 K
  • EBIT $ 220 M
  • EBITDA $ 218 M
  • 60-Month Beta 0.79
  • Price/Sales 3.66
  • Price/Cash Flow 29.48
  • Price/Book 4.49

Options Overview Details

View History
  • Implied Volatility 49.97% ( +5.05%)
  • Historical Volatility 104.26%
  • IV Percentile 56%
  • IV Rank 15.43%
  • IV High 147.45% on 05/29/24
  • IV Low 32.18% on 01/22/25
  • Put/Call Vol Ratio 0.52
  • Today's Volume 1,594
  • Volume Avg (30-Day) 3,869
  • Put/Call OI Ratio 0.53
  • Today's Open Interest 42,220
  • Open Int (30-Day) 35,500

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 22 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 1.74
  • Number of Estimates 6
  • High Estimate 2.31
  • Low Estimate 1.50
  • Prior Year 0.38
  • Growth Rate Est. (year over year) +357.89%

Price Performance

See More
Period Period Low Period High Performance
1-Month
65.97 unch
on 03/31/25
Period Open: 106.75
107.77 -38.78%
on 03/05/25
-40.78 (-38.20%)
since 02/28/25
3-Month
65.97 unch
on 03/31/25
Period Open: 121.50
129.84 -49.19%
on 01/07/25
-55.53 (-45.70%)
since 12/27/24
52-Week
65.97 unch
on 03/31/25
Period Open: 129.46
173.25 -61.92%
on 06/21/24
-63.49 (-49.04%)
since 03/28/24

Most Recent Stories

More News
Q4 Rundown: Moderna (NASDAQ:MRNA) Vs Other Therapeutics Stocks

Q4 Rundown: Moderna (NASDAQ:MRNA) Vs Other Therapeutics Stocks

SRPT : 65.97 (-6.30%)
BMRN : 68.45 (-4.19%)
ABBV : 204.15 (-0.56%)
MRNA : 27.62 (-11.25%)
BIIB : 137.40 (-0.70%)
Is This Stock a Buy After a Massive 20% Drop in 1 Day?

Things are going from bad to worse for Sarepta Therapeutics (NASDAQ: SRPT), a biotech focusing on gene therapies. The company's performance over the past six months had already been unimpressive. But on...

SRPT : 65.97 (-6.30%)
Q4 Earnings Review: Therapeutics Stocks Led by BioMarin Pharmaceutical (NASDAQ:BMRN)

Q4 Earnings Review: Therapeutics Stocks Led by BioMarin Pharmaceutical (NASDAQ:BMRN)

SRPT : 65.97 (-6.30%)
BMRN : 68.45 (-4.19%)
GILD : 109.40 (-2.14%)
MRNA : 27.62 (-11.25%)
AMGN : 306.43 (-0.17%)
Sarepta Therapeutics Stock Has A Nightmarish Week After DMD Patient Death, But Retail And Analysts Aren't Giving Up

Jefferies acknowledged acute liver failure could signal a new safety risk but maintained that the high unmet need for DMD treatments supports the bull case.

SRPT : 65.97 (-6.30%)
IJH : 57.63 (-1.00%)
VTI : 270.48 (-1.08%)
XBI : 82.12 (-2.70%)
Company News for Mar 19, 2025

Shares of Sarepta Therapeutics, Inc. SRPT plunged 27.4% after the company reported a patient death linked to its Elevidys gene therapy, sparking safety concerns.IHS Holding Limited IHS shares surged 13.2%...

BTU : 13.16 (-4.08%)
IHS : 5.28 (-0.75%)
SRPT : 65.97 (-6.30%)
MRP : 26.36 (-0.60%)
Stocks Settle Lower as Megacap Tech Stocks Routed

The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -1.07%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.62%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -1.66%. March E-mini...

MSTR : 282.30 (-2.46%)
GOOGL : 153.15 (-0.76%)
AAPL : 217.01 (-0.41%)
ETR : 84.00 (-0.49%)
SRPT : 65.97 (-6.30%)
ADI : 200.00 (-0.77%)
ELV : 432.00 (+0.01%)
TSLA : 248.81 (-5.59%)
WTW : 337.16 (-1.09%)
SPY : 550.78 (-0.88%)
META : 565.73 (-1.91%)
MU : 86.02 (-2.74%)
Patient dies following muscular dystrophy gene therapy, Sarepta reports

A patient has died while taking a closely watched gene therapy for muscular dystrophy

SRPT : 65.97 (-6.30%)
$SPX : 5,580.94 (-1.97%)
$DOWI : 41,583.90 (-1.69%)
$IUXX : 19,281.40 (-2.61%)
Why Sarepta Therapeutics (SRPT) Shares Are Sliding Today

Why Sarepta Therapeutics (SRPT) Shares Are Sliding Today

SRPT : 65.97 (-6.30%)
Stocks Retreat on Weakness in Technology Stocks

The S&P 500 Index ($SPX ) (SPY ) today is down -1.15%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.67%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.89%. March E-mini S&P futures...

MSTR : 282.30 (-2.46%)
GOOGL : 153.15 (-0.76%)
UAL : 67.78 (-3.49%)
CVS : 66.50 (-0.95%)
ETR : 84.00 (-0.49%)
AVGO : 164.82 (-2.54%)
SRPT : 65.97 (-6.30%)
$IUXX : 19,281.40 (-2.61%)
UNH : 517.54 (+0.29%)
ELV : 432.00 (+0.01%)
ZNM25 : 111-155 (+0.25%)
MSFT : 374.00 (-1.27%)
Stocks Slide on Economic Growth Concerns

The S&P 500 Index ($SPX ) (SPY ) today is down -1.01%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.50%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.73%. March E-mini S&P futures...

MSTR : 282.30 (-2.46%)
GOOGL : 153.15 (-0.76%)
MPC : 144.10 (-2.21%)
ETR : 84.00 (-0.49%)
AVGO : 164.82 (-2.54%)
SRPT : 65.97 (-6.30%)
$IUXX : 19,281.40 (-2.61%)
BWA : 27.79 (-1.42%)
ZNM25 : 111-155 (+0.25%)
MSFT : 374.00 (-1.27%)
TSLA : 248.81 (-5.59%)
ESM25 : 5,571.75 (-0.91%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company that focuses on the discovery and development of RNA-based therapeutics targeting rare and infectious diseases. It concentrates on the development of exon-skipping drug candidates targeting Duchenne muscular dystrophy (DMD), a...

See More

Key Turning Points

3rd Resistance Point 73.95
2nd Resistance Point 73.00
1st Resistance Point 71.71
Last Price 65.97
1st Support Level 69.46
2nd Support Level 68.51
3rd Support Level 67.21

See More

52-Week High 173.25
Fibonacci 61.8% 132.27
Fibonacci 50% 119.61
Fibonacci 38.2% 106.95
Last Price 65.97
52-Week Low 65.97

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trading Volatility: How to Use IV Rank & Percentile for Smarter Options Strategies